504 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
Rank Status Study
21 Recruiting HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients
Conditions: Infertility;   Polycystic Ovarian Syndrome
Interventions: Drug: Estradiol valerate;   Drug: Sequential Clomiphene citrate and Gonadotropin
22 Unknown  Therapeutic Monitoring of Metformin in Women With Polycystic Ovary Syndrome
Condition: Polycystic Ovary Syndrome
Intervention: Drug: Metformin
23 Recruiting The Secretion of Incretin Hormones in Patients With Polycystic Ovary Syndrome
Condition: Polycystic Ovary Syndrome
Intervention:
24 Recruiting Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery
Conditions: Male Breast Cancer;   Recurrent Melanoma;   Stage IV Breast Cancer;   Stage IV Melanoma;   Stage IV Ovarian Epithelial Cancer;   Stage IV Ovarian Germ Cell Tumor;   Unspecified Adult Solid Tumor, Protocol Specific;   Hepatocellular Carcinoma
Interventions: Drug: propranolol hydrochloride;   Other: Correlative Studies
25 Recruiting Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers
Condition: Hereditary Breast and Ovarian Cancer
Intervention: Behavioral: Structured exercise training plus mediterranean diet
26 Recruiting GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer
Conditions: Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer
Interventions: Drug: Ganetespib;   Drug: Paclitaxel
27 Recruiting A Phase-I, Dose Escalation Study of Recombinant Human Interleukin-18 (Sb-485232) Combined With Adoptive Transfer of Vaccine-Primed CD3/CD28-Costimulated Autologous T-Cells Following Lymphodepletion for Adult Patients With Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Condition: Recurrent Ovarian Carcinoma, Fallopian Tube or Primary Peritoneal Cancer,
Interventions: Biological: Vaccine--‐primed, CD3/CD28--‐costimulated autologous peripheral blood T--‐cells;   Biological: SB--‐485232 (Human recombinant Interleukin--‐18)
28 Recruiting Tocotrienol as a Nutritional Supplement in Patients With Advanced Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Bevacizumab;   Drug: Tocotrinol
29 Unknown  CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Drug: tamoxifen citrate;   Other: diagnostic laboratory biomarker analysis
30 Unknown  Clomiphene Citrate Plus uFSH Versus Aromatase Inhibitor Plus uFSH in Clomiphene Resistant Infertile PCOS Women
Conditions: Polycystic Ovary Syndrome;   Infertility
Interventions: Drug: Aromatase inhibitor (litrezole) plus uFSH arm;   Drug: clomiphene citrate-uFSH arm
31 Unknown  Lifestyle Intervention for Polycystic Ovary Syndrome: Pulse-Based Diet and Exercise
Conditions: Polycystic Ovary Syndrome;   Metabolic Syndrome
Interventions: Other: Pulse-based diet;   Other: TLC diet
32 Unknown  Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS
Condition: Ovarian Hyperstimulation Syndrome
Intervention: Drug: hCG
33 Unknown  Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion Chemotherapy
Condition: Ovarian Cancer With Malignant Ascites
Interventions: Drug: Bevacizumab;   Drug: TC:paclitaxel + carboplatin
34 Not yet recruiting Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Conditions: Marfan Syndrome;   Loeys-Dietz Syndrome;   Thoracic Aortic Aneurysm and Dissection Syndromes;   Ehlers-Danlos Type IV Syndrome;   Turner Syndrome
Intervention:
35 Recruiting Extended Clomiphene Citrate Regimen in Women With Polycystic Ovary Syndrome
Condition: Infertility
Interventions: Drug: clomiphene citrate;   Procedure: laparoscopic ovarian drilling (LOD)
36 Recruiting COsegregation of VARiants in the BRCA1/2 Genes
Conditions: Genes, BRCA1;   Genes, BRCA2;   Ovarian Neoplasms;   Breast Neoplasms
Intervention: Genetic: salivary kit
37 Recruiting Orteronel (TAK-700) in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors. The Greko II Study.
Condition: Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors
Intervention: Drug: Orteronel 300mg BID
38 Recruiting Tivozanib As Maintenance Therapy In GYN
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Carcinoma
Intervention: Drug: Tivozanib
39 Recruiting CART-meso in Mesothelin Expressing Cancers
Conditions: Metastatic Pancreatic (Ductal) Adenocarcinoma;   Epithelial Ovarian Cancer;   Malignant Epithelial Pleural Mesothelioma
Intervention: Biological: CART-meso
40 Not yet recruiting Autologous Dendritic Cell-Tumor Cell Immunotherapy for Advanced Epithelial Ovarian Carcinomas
Conditions: Stage III Ovarian Carcinoma;   Stage IV Ovarian Carcinoma;   Fallopian Tube Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Biological: ovapuldencel-T;   Biological: MC: Autologous PBMCs in GM-CSF

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years